Serum markers associated with treatment response and survival in non-small cell lung cancer patients treated with anti-PD-1 therapy-Reference-Cited by-同舟云学术

Serum markers associated with treatment response and survival in non-small cell lung cancer patients treated with anti-PD-1 therapy

Published:2020-07 Issue: Volume:145 Page:18-26
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Takada Kazuki,Takamori Shinkichi,Yoneshima Yasuto,Tanaka Kentaro,Okamoto Isamu,Shimokawa Mototsugu,Oba Taro,Osoegawa Atsushi,Tagawa Tetsuzo,Takenoyama Mitsuhiro,Oda Yoshinao,Nakanishi Yoichi,Mori Masaki

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Predictive markers for the efficacy of Anti-PD-1/PD-L1 antibodies in lung Cancer;Shukuya;J. Thorac. Oncol.,2016

2. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer;Rizvi;Science (New York, N.Y.),2015

3. Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature;Ribas;ASCO Annual Meeting Abstract,2015

4. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer;Bagley;Lung Cancer (Amsterdam, Netherlands),2017

5. High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer;Okuma;Lung Cancer (Amsterdam, Netherlands),2017

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer;Scientific Reports;2024-08-23

2. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio: Side by Side with Molecular Mutations in Patients with Non-Small Cell Lung Cancer—The INOLUNG Study;Cancers;2024-08-21

3. Prognostic significance of hemoglobin, albumin, lymphocyte, and platelet (HALP) score in breast cancer: a propensity score-matching study;Cancer Cell International;2024-07-02

4. Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer;Frontiers in Oncology;2024-06-20

5. Value of computed tomography radiomics combined with inflammation indices in predicting the efficacy of immunotherapy in patients with locally advanced and metastatic non-small cell lung cancer;Journal of Thoracic Disease;2024-05